Accounts payable and accrued expenses consist of the following (in thousands):


	June 30, 2025		December 31, 2024
Accounts payable	$	42,065	$	46,431
Accrued salaries and incentive compensation		133,585		215,357
Accrued payroll taxes and benefits		31,377		35,450
Accrued professional liabilities		30,607		30,430
Accrued interest		8,157		8,159
Other accrued expenses		57,569		62,863
	$	303,360	$	398,690

The net decrease in accrued salaries and incentive compensation of $81.8 million, from December 31, 2024 to June 30, 2025, is primarily due to the payment of performance-based incentive compensation, principally to the Company’s affiliated physicians, partially offset by performance-based incentive compensation accrued during the six months ended June 30, 2025. A majority of the Company’s payments for performance-based incentive compensation is paid annually during the first quarter.